A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS Review uri icon

Overview

MeSH Major

  • Blood Sedimentation
  • C-Reactive Protein
  • Inflammatory Bowel Diseases
  • Irritable Bowel Syndrome
  • Lactoferrin
  • Leukocyte L1 Antigen Complex

abstract

  • CRP and calprotectin of ≤0.5 or 40, respectively, essentially excludes IBD in patients with IBS symptoms. The addition of CRP and calprotectin to symptom-based criteria may improve the confident diagnosis of IBS.

publication date

  • January 2015

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1038/ajg.2015.6

PubMed ID

  • 25732419

Additional Document Info

start page

  • 444

end page

  • 54

volume

  • 110

number

  • 3